Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichiro Yuji

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
The Malaysian Journal of Medical Sciences : MJMS|September 28, 2017
Organophosphate Poisoning and TerrorismTetsuya Tanimoto, Yasuo Oshima, Koichiro Yuji, et al.
Lancet (London, England)|December 7, 2010
Japan's health policyKoichiro Yuji, Tomoko Matsumura, Yuko Kodama, et al.
Internal Medicine (Tokyo, Japan)|October 4, 2013
Association between acute myelogenous leukemia and thrombopoietin receptor agonists in patients with immune thrombocytopeniaYasuo Oshima, Koichiro Yuji, Tetsuya Tanimoto, et al.
Lancet (London, England)|August 3, 2010
Human papillomavirus vaccine coverageKoichiro Yuji, Tomoko Matsumura, Satoru Miyano, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|August 13, 2008
Current status of the Japanese cancer registry system: results of a nationwide surveyTomohiro Sawa, Koichiro Yuji, Masahiro Kami, et al.
Plos One|March 14, 2013
Does Twitter trigger bursts in signature collections?Rui Yamaguchi, Seiya Imoto, Masahiro Kami, et al.
Ecancermedicalscience|March 3, 2015
How do medical journalists treat cancer-related issues?Haruka Nakada, Masaharu Tsubokura, Yukiko Kishi, et al.
Clinical Case Reports|July 18, 2015
Treatment of chronic lymphocytic leukemia with bendamustine in an HIV-infected patient on antiretroviral therapy: a case report and review of the literatureNaoki Shimada, Koichiro Yuji, Nobuhiro Ohno, et al.
Asian Bioethics Review|May 16, 2022
Public Attitudes toward COVID-19 Vaccinations before Dawn in Japan: Ethics and Future PerspectivesHaruka Nakada, Kyoko Takashima, Yuichi Maru, et al.
International Journal of Hematology|April 10, 2013
Development of peripheral T-cell lymphoma not otherwise specified in an HTLV-1 carrierTomohiro Ishigaki, Masamichi Isobe, Seiichiro Kobayashi, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
The Malaysian Journal of Medical Sciences : MJMS|September 28, 2017
Organophosphate Poisoning and TerrorismTetsuya Tanimoto, Yasuo Oshima, Koichiro Yuji, et al.
Lancet (London, England)|December 7, 2010
Japan's health policyKoichiro Yuji, Tomoko Matsumura, Yuko Kodama, et al.
Internal Medicine (Tokyo, Japan)|October 4, 2013
Association between acute myelogenous leukemia and thrombopoietin receptor agonists in patients with immune thrombocytopeniaYasuo Oshima, Koichiro Yuji, Tetsuya Tanimoto, et al.
Lancet (London, England)|August 3, 2010
Human papillomavirus vaccine coverageKoichiro Yuji, Tomoko Matsumura, Satoru Miyano, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|August 13, 2008
Current status of the Japanese cancer registry system: results of a nationwide surveyTomohiro Sawa, Koichiro Yuji, Masahiro Kami, et al.
Plos One|March 14, 2013
Does Twitter trigger bursts in signature collections?Rui Yamaguchi, Seiya Imoto, Masahiro Kami, et al.
Ecancermedicalscience|March 3, 2015
How do medical journalists treat cancer-related issues?Haruka Nakada, Masaharu Tsubokura, Yukiko Kishi, et al.
Clinical Case Reports|July 18, 2015
Treatment of chronic lymphocytic leukemia with bendamustine in an HIV-infected patient on antiretroviral therapy: a case report and review of the literatureNaoki Shimada, Koichiro Yuji, Nobuhiro Ohno, et al.
Asian Bioethics Review|May 16, 2022
Public Attitudes toward COVID-19 Vaccinations before Dawn in Japan: Ethics and Future PerspectivesHaruka Nakada, Kyoko Takashima, Yuichi Maru, et al.
International Journal of Hematology|April 10, 2013
Development of peripheral T-cell lymphoma not otherwise specified in an HTLV-1 carrierTomohiro Ishigaki, Masamichi Isobe, Seiichiro Kobayashi, et al.
Pageof 9